MA24643A1 - Tetrahydro-naphtalenes substitues et composes analogues - Google Patents

Tetrahydro-naphtalenes substitues et composes analogues

Info

Publication number
MA24643A1
MA24643A1 MA25245A MA25245A MA24643A1 MA 24643 A1 MA24643 A1 MA 24643A1 MA 25245 A MA25245 A MA 25245A MA 25245 A MA25245 A MA 25245A MA 24643 A1 MA24643 A1 MA 24643A1
Authority
MA
Morocco
Prior art keywords
naphthalenes
substituted tetrahydro
similar compounds
compounds
pharmaceuticals
Prior art date
Application number
MA25245A
Other languages
English (en)
Inventor
Bremm Klaus-Dieter
Schmidt Gunter
Brandes Arndt
Schmidt Delf
Naab Paul
Stoltefub Jurgen
Logers Michael
Bischoff Hilmar
Schmeck Carsten
Paulsen Holger
Antons Stefan
Nicholas Muller Stephan
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19832159A external-priority patent/DE19832159A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MA24643A1 publication Critical patent/MA24643A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/48—Halogenated derivatives
    • C07C35/52—Alcohols with a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/18—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/192—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
MA25245A 1997-09-18 1998-09-08 Tetrahydro-naphtalenes substitues et composes analogues MA24643A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19741050 1997-09-18
DE19832159A DE19832159A1 (de) 1997-09-18 1998-07-17 Substituierte Tetrahydro-naphthaline

Publications (1)

Publication Number Publication Date
MA24643A1 true MA24643A1 (fr) 1999-04-01

Family

ID=26040079

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25245A MA24643A1 (fr) 1997-09-18 1998-09-08 Tetrahydro-naphtalenes substitues et composes analogues

Country Status (9)

Country Link
US (1) US6586613B1 (fr)
EP (1) EP1017659B1 (fr)
JP (1) JP2001516732A (fr)
AT (1) ATE294152T1 (fr)
AU (1) AU9744298A (fr)
ES (1) ES2242302T3 (fr)
MA (1) MA24643A1 (fr)
PT (1) PT1017659E (fr)
WO (1) WO1999014174A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19935966A1 (de) * 1999-07-30 2001-02-01 Bayer Ag Verfahren zur Reduktion von Ketoalkoholen
US7115279B2 (en) 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
TNSN03138A1 (fr) 2001-06-22 2005-12-23 Pfizer Prod Inc Compositions pharmaceutiques d'adsorbats d'un medicament amorphe
EP1269994A3 (fr) * 2001-06-22 2003-02-12 Pfizer Products Inc. Compositions Pharmaceutiques comprenant un médicament et un polymère permettant d'améliorer la concentration du médicament
ATE444060T1 (de) 2001-06-22 2009-10-15 Pfizer Prod Inc Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
DE10148436A1 (de) * 2001-10-01 2003-04-17 Bayer Ag Tetrahydrochinoline
FR2832919B1 (fr) 2001-12-04 2004-02-20 Imv Technologies Seringue d'injection du contenu d'une paillette pour l'insemination artificielle d'un animal ou le transfert embryonnaire
WO2003053359A2 (fr) 2001-12-19 2003-07-03 Atherogenics, Inc. 1,3-bis-(phenyl-substitue)-2-propyne-1-ones et leur utilisation pour le traitement d'affections
JP2005516941A (ja) 2001-12-19 2005-06-09 アセロジエニクス・インコーポレイテツド カルコン誘導体及び疾患を治療するためのそれらの使用
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
CA2474838C (fr) 2002-02-01 2009-01-06 Pfizer Products Inc. Compositions pharmaceutiques de dispersions amorphes de medicaments et materiaux formant des microphases lipophiles
BR0317521A (pt) 2002-12-20 2005-11-16 Pfizer Prod Inc Formas de dosagem compreendendo um inibidor da cetp e um inibidor da redutase hmg-coa
MXPA05009848A (es) 2003-03-17 2005-12-06 Japan Tobacco Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia del ester de colesterilo.
TWI494102B (zh) * 2003-05-02 2015-08-01 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
BRPI0413277A (pt) 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas
BRPI0414822A (pt) * 2003-09-26 2006-11-14 Japan Tobacco Inc método de inibir a produção de lipoproteìna remanescente
US8124775B2 (en) * 2004-12-18 2012-02-28 Bayer Pharma Aktiengesellschaft Chemical compound and its use
EP1844078B1 (fr) 2005-02-03 2016-09-28 Bend Research, Inc Compositions pharmaceutiques a efficacite amelioree
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
WO2007048027A2 (fr) 2005-10-21 2007-04-26 Novartis Ag Combinaison de composes organiques
DE102006012548A1 (de) * 2006-03-18 2007-09-20 Bayer Healthcare Ag Substituierte Chromanol-Derivate und ihre Verwendung
PL2268644T3 (pl) * 2008-03-05 2012-01-31 Boehringer Ingelheim Int Tricykliczne pochodne piperydyny, leki zawierające te związki, ich zastosowanie i sposoby ich wytwarzania
WO2010075069A1 (fr) 2008-12-16 2010-07-01 Schering Corporation Dérivés de pyranone bicycliques en tant qu'agonistes des récepteurs nicotiniques
EP2379547A1 (fr) 2008-12-16 2011-10-26 Schering Corporation Dérivés de pyridopyrimidine et leurs procédés d'utilisation
TWI506025B (zh) 2010-07-09 2015-11-01 Daiichi Sankyo Co Ltd 取代吡啶化合物
EP3191441B1 (fr) * 2014-09-09 2020-02-19 Boehringer Ingelheim International Trading (Shanghai) Co. Ltd. Nouveau procédé de préparation de spiro[2,5]octane-5,7-dione et de spiro[3,5]nonane-6,8-dione

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169857A (en) 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
US5446207A (en) 1993-09-01 1995-08-29 Harbor Branch Oceanographic Institution, Inc. Anti-dyslipidemic agents
HRP970330B1 (en) 1996-07-08 2004-06-30 Bayer Ag Cycloalkano pyridines

Also Published As

Publication number Publication date
AU9744298A (en) 1999-04-05
WO1999014174A1 (fr) 1999-03-25
EP1017659A1 (fr) 2000-07-12
ATE294152T1 (de) 2005-05-15
PT1017659E (pt) 2005-09-30
EP1017659B1 (fr) 2005-04-27
US6586613B1 (en) 2003-07-01
ES2242302T3 (es) 2005-11-01
JP2001516732A (ja) 2001-10-02

Similar Documents

Publication Publication Date Title
MA24643A1 (fr) Tetrahydro-naphtalenes substitues et composes analogues
ID23374A (id) Halogenopirimidin
FI963070A (fi) Klooripyrimidiinivälituotteita
NO990544L (no) Substituerte pyrido- eller pyrimido-inneholdende 6,6 eller 6,7-bycykliske derivater
BR9612258B1 (pt) inibidores de enzima conversora de interleucina-1beta, bem como composição farmacêutica.
DE68924197D1 (de) Keine Fäden ziehende, feuchtigkeitshärtende Zusammensetzungen.
ES2146774T3 (es) Polimeros de ioneno que contienen aniones biologicamente activos.
CO5210911A1 (es) Trifluorbutenos nematicidas
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
ATE288900T1 (de) Substituierte benzoylcyclohexandione
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
DK1204659T3 (da) Serotonerge benzofuraner
DE60001366T2 (de) Orale zusammensetzung enthaltend perlit
ID27733A (id) Metoksiminofenilasetamida
DE69409961T2 (de) Triarylethylenderivate zur therapeutischen verwendung
AU6832498A (en) Substituted benzyl oximino compounds
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
CO5150221A1 (es) Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas
SE9602416D0 (sv) New forms of an organic salt of N'N-diacetylcystine
ATE68486T1 (de) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl - 1h-imidazol.
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
MX9804068A (es) Nuevos derivados de quinoxalindiona, su preparacion y empleo en medicamentos.
BG102613A (en) New substituted imidazoles
DE29612851U1 (de) Bauelement, sowie Gruppe von Bauelementen
WO2001005805A3 (fr) Nouveaux steroides substitues par halogene en c-19 de la serie androst-9(11)-ene, procedes permettant de les preparer et leur utilisation